… In summary, our computational molecular docking approach and virtual screening identified
some promising candidate SARS-CoV-2 inhibitors that may be considered for further clinical …

… The inhibition of the SARS-CoV-2 main protease is necessary for the blockage of the viral …
a blind molecular docking approach to identify the possible inhibitors of the SARS-CoV-2 main …

… In the current spread of novel coronavirus (SARS-CoV-2), antiviral drug discovery is of … by
molecular docking with the structural protein and non-structural protein sites of new coronavirus…

… The enzyme SARS-CoV-2 Mpro along with other proteases is involved in the generation
of various nonstructural proteins by cleaving the polyproteins (translated from viral RNA) at …

… SARS-CoV-2 virus. An immediately qualifying strategy would be to use existing powerful drugs
from various virus … would be to identify promising drug molecules, as there is currently no …

… drugs for COVID-19, we have also conducted molecular docking studies with SARS-CoV-2
PL … Among SARS-CoV-2 PL pro , SARS PL pro , MERS PL pro , Rhinolophus affinis PL pro , …

… sites of SARS-CoV-2, we performed molecular docking studies. Molecular docking is an in-…
is generally a small molecule) in which it will bind to an active site of the receptor. There are …

… molecular complex between TMPRSS2 and SARS-CoV-2 … of molecular interactions between
TMPRSS2 and SARS-CoV-2 … inhibitor molecules, targeting the viral entry into the host cell. …

… Molecular docking is used to identify Rutin as a potentially active phytochemical against
SARS CoV-2 … The schematic representation of the genomic organization of SARS-Cov-2 is …

… molecular docking analysis of commonly occurring natural product compounds against
COVID-19 … have binding affinity against both the COVID-19 proteases, and compare well with a …